Medicare Enrolled
Dr. Arkady Gendelman, M.D.
Family Medicine · San Francisco, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gendelman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gendelman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gendelman
Dr. Arkady Gendelman is a family medicine specialist in San Francisco, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Gendelman performed 1,363 Medicare services across 842 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gendelman received a total of $15,255 from 51 pharmaceutical and/or device companies across 532 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gendelman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 16% volume in CA
$15,255 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,363
Medicare services
Top 16% in CA for family medicine
842
Unique beneficiaries
$91
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~72 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
221 | $103 | $258 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
200 | $71 | $176 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
161 | $81 | $140 |
| Home visit, established patient, moderate complexity A home visit for an established patient involving moderate medical decision making. The visit requires at least 40 minutes of time if time is used to determine the level of service. |
140 | $108 | $293 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
132 | $153 | $279 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
117 | $108 | $180 |
| Home visit, established patient, low complexity A physician visits an existing patient at their residence to provide care involving a low level of medical decision making. The visit lasts at least 30 minutes. |
86 | $59 | $193 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
67 | $36 | $40 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 66 | $20 | $45 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
48 | $48 | $130 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
35 | $155 | $369 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
31 | $36 | $40 |
| Pneumococcal vaccine, 23-valent A vaccine that protects against 23 types of pneumococcal bacteria. It is used to prevent infections caused by these bacteria. |
28 | $131 | $160 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
17 | $192 | $398 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
14 | $64 | $150 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$15,255
Total received (2018-2024)
Avg $2,179/year across 7 years
Top 2% in CA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
532
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,255 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,651
2023
$1,739
2022
$1,356
2021
$2,604
2020
$1,190
2019
$3,164
2018
$2,550
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$584
ABBVIE INC.
$407
Currax Pharmaceuticals LLC
$310
Amgen Inc.
$265
Novo Nordisk Inc
$214
GlaxoSmithKline, LLC.
$202
PFIZER INC.
$187
AstraZeneca Pharmaceuticals LP
$150
Phathom Pharmaceuticals, Inc.
$126
Novartis Pharmaceuticals Corporation
$97
IDORSIA PHARMACEUTICALS US INC
$59
IRONWOOD PHARMACEUTICALS, INC
$26
Boehringer Ingelheim Pharmaceuticals, Inc.
$23
Top 3 companies account for 49.1% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$1,809
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,417
AstraZeneca Pharmaceuticals LP
$1,099
Amgen Inc.
$1,004
Amarin Pharma Inc.
$817
ABBVIE INC.
$776
Neurocrine Biosciences, Inc.
$739
AbbVie Inc.
$542
Currax Pharmaceuticals LLC
$510
PFIZER INC.
$462
Novo Nordisk Inc
$449
GlaxoSmithKline, LLC.
$411
Teva Pharmaceuticals USA, Inc.
$382
Novartis Pharmaceuticals Corporation
$376
Janssen Pharmaceuticals, Inc
$353
AbbVie, Inc.
$352
Allergan Inc.
$336
Biohaven Pharmaceuticals, Inc.
$292
OptiNose US, Inc.
$278
Eisai Inc.
$248
RedHill Biopharma Inc.
$197
Biohaven Pharmaceutical Holding Company Ltd.
$190
Radius Health, Inc.
$186
Merck Sharp & Dohme Corporation
$186
Merck Sharp & Dohme LLC
$154
Kowa Pharmaceuticals America, Inc.
$145
IDORSIA PHARMACEUTICALS US INC
$135
Bausch Health US, LLC
$135
Phathom Pharmaceuticals, Inc.
$126
Bayer Healthcare Pharmaceuticals Inc.
$125
Optinose US, Inc.
$116
Astellas Pharma US Inc
$110
Relypsa, Inc.
$100
Synergy Pharmaceuticals Inc
$94
Takeda Pharmaceuticals U.S.A., Inc.
$82
Regeneron Healthcare Solutions, Inc.
$60
Ironwood Pharmaceuticals, Inc
$60
Allergan, Inc.
$50
IRONWOOD PHARMACEUTICALS, INC
$45
Exact Sciences Corporation
$44
Promius Pharma LLC
$34
Sumitomo Pharma America, Inc.
$33
ARBOR PHARMACEUTICALS, INC.
$27
E.R. Squibb & Sons, L.L.C.
$24
Sunovion Pharmaceuticals Inc.
$24
Kyowa Kirin, Inc.
$23
EISAI INC.
$23
Avanir Pharmaceuticals, Inc.
$20
Arbor Pharmaceuticals, Inc.
$19
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$18
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$17
Top 3 companies account for 28.4% of all-time payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · APLENZIN · AREXVY · Aimovig · Amitiza · BASAGLAR · BELSOMRA · BEVESPI AEROSPHERE · BREZTRI · BYDUREON · BYVALSON · CHANTIX · COLOGUARD · COMIRNATY · CONTRAVE · CREON · Cologuard Collection Kit · Creon · Dayvigo · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Edarbi · FARXIGA · GEMTESA · GLYXAMBI · INGREZZA · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LINZESS · LifeVest · Linzess · Livalo · MOUNJARO · MYRBETRIQ · Motegrity · Movantik · Myrbetriq · NEXLETOL · NUEDEXTA · NURTEC ODT · ONGENTYS · ONZETRA XSAIL · Otezla · Ozempic · PAXLOVID · PRALUENT · PREVNAR 20 · Prolia · QULIPTA · QUVIVIQ · Repatha · Rybelsus · SHINGRIX · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · Saxenda · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · Talicia · Trulance · Tymlos · UBRELVY · VESICARE · VIBERZI · VOQUEZNA · VRAYLAR · Vascepa · Veltassa · Wegovy · XARELTO · XIFAXAN · XIGDUO · Xhance · Xultophy 100/3.6 · ZENPEP · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for family medicine in CA.
Geographic Context
Family medicine physicians within 10 mi
1,492
Per 100K population
178.4
County median income
$141,446
Nearest hospital
KAISER FOUNDATION HOSPITAL - SAN FRANCISCO
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Gendelman is a clinical cardiology specialist, with above-average Medicare volume (top 16% in CA), with low-engagement industry engagement in the top 2% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Gendelman experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Gendelman performed 221 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gendelman receive payments from pharmaceutical companies?
Yes. Dr. Gendelman received a total of $15,255 from 51 companies across 532 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gendelman's costs compare to other family medicine physicians in San Francisco?
Dr. Gendelman's average Medicare payment per service is $91. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gendelman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in San Francisco
Browse family medicine physicians in San Francisco ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in CA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in CA
Which CA family medicine physicians receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology